- Home
- LNW vs MEDP Comparison
LNW vs MEDP Comparison
Compare LNW & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- MEDP
- Stock Information
- Founded
- LNW 1984
- MEDP 1992
- Country
- LNW United States
- MEDP United States
- Employees
- LNW N/A
- MEDP N/A
- Industry
- LNW EDP Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LNW Technology
- MEDP Health Care
- Exchange
- LNW Nasdaq
- MEDP Nasdaq
- Market Cap
- LNW 8.5B
- MEDP 8.5B
- IPO Year
- LNW N/A
- MEDP 2016
- Fundamental
- Price
- LNW $78.86
- MEDP $434.35
- Analyst Decision
- LNW Buy
- MEDP Hold
- Analyst Count
- LNW 11
- MEDP 10
- Target Price
- LNW $108.18
- MEDP $406.89
- AVG Volume (30 Days)
- LNW 989.4K
- MEDP 755.1K
- Earning Date
- LNW 08-06-2025
- MEDP 07-21-2025
- Dividend Yield
- LNW N/A
- MEDP N/A
- EPS Growth
- LNW 19.32
- MEDP 26.42
- EPS
- LNW 3.95
- MEDP 13.46
- Revenue
- LNW $3,195,000,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- LNW $8.88
- MEDP $19.15
- Revenue Next Year
- LNW $7.69
- MEDP $9.35
- P/E Ratio
- LNW $19.97
- MEDP $32.28
- Revenue Growth
- LNW 3.83
- MEDP 9.94
- 52 Week Low
- LNW $69.56
- MEDP $250.05
- 52 Week High
- LNW $115.00
- MEDP $501.30
- Technical
- Relative Strength Index (RSI)
- LNW 26.57
- MEDP 63.69
- Support Level
- LNW $69.56
- MEDP $424.56
- Resistance Level
- LNW $99.99
- MEDP $439.99
- Average True Range (ATR)
- LNW 3.31
- MEDP 20.05
- MACD
- LNW -2.40
- MEDP -1.82
- Stochastic Oscillator
- LNW 30.18
- MEDP 24.73
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.